BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 36 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,692 | +23.2% | 4,737,000 | +25.1% | 0.01% | +40.0% |
Q2 2023 | $3,808 | +20.4% | 3,788,000 | +24.9% | 0.01% | +25.0% |
Q1 2023 | $3,163 | -41.3% | 3,033,000 | -39.5% | 0.00% | -42.9% |
Q4 2022 | $5,385 | -99.9% | 5,011,000 | -7.8% | 0.01% | -12.5% |
Q3 2022 | $5,397,000 | -13.8% | 5,434,000 | -13.8% | 0.01% | 0.0% |
Q2 2022 | $6,264,000 | -7.1% | 6,303,000 | -6.4% | 0.01% | +14.3% |
Q1 2022 | $6,743,000 | +6.9% | 6,734,000 | +11.3% | 0.01% | +16.7% |
Q4 2021 | $6,310,000 | -17.0% | 6,049,000 | -20.3% | 0.01% | -25.0% |
Q3 2021 | $7,599,000 | -0.1% | 7,593,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $7,608,000 | – | 7,593,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVENT CAPITAL MANAGEMENT /DE/ | 70,652,000 | $71,212,000 | 1.38% |
SHENKMAN CAPITAL MANAGEMENT INC | 14,821,000 | $14,947,000 | 1.36% |
AQR Arbitrage LLC | 21,650,000 | $21,800,000 | 0.61% |
Worth Venture Partners, LLC | 708,000 | $714,000 | 0.27% |
LOOMIS SAYLES & CO L P | 2,366,716 | $197,478,000 | 0.24% |
MACKAY SHIELDS LLC | 24,500,000 | $24,670,000 | 0.23% |
CAMDEN ASSET MANAGEMENT L P /CA | 2,500,000 | $2,505,000 | 0.10% |
PALISADE CAPITAL MANAGEMENT, LP | 2,429,000 | $2,442,000 | 0.06% |
Alberta Investment Management Corp | 5,500,000 | $5,545,000 | 0.05% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 1,900,000 | $1,913,000 | 0.04% |